Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma

NCT00242827 is registered in ClinicalTrials.gov with Cephalon as lead sponsor.

NCT NCT00242827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00242827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
Lead sponsor
Cephalon
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2006
Completion date
May 31, 2007
Enrollment
Not reported
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

myeloma